Cytokines and adhesion molecules in middle ear cholesteatoma. A role in epithelial growth?

Acta Oto-Laryngologica

Volumn 119, Issue 4, 1999, Pages 462-467

  Ottaviani, Francesco ^a   Neglia, Cesare Bartolomeo ^a   Berti, Emilio ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Adhesion molecules; Cytokines; Immunohistochemistry; Middle ear cholesteatoma

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; CD32 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GAMMA INTERFERON; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1;

ANTIBODY DETECTION; ARTICLE; CELL ADHESION; CELL GROWTH; CHOLESTEATOMA; CLINICAL ARTICLE; CYTOKINE RELEASE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAST CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIBODIES, MONOCLONAL; CELL ADHESION MOLECULES; CHOLESTEATOMA, MIDDLE EAR; CYTOKINES; EPITHELIUM; HUMANS; IMMUNOHISTOCHEMISTRY;

EID: 0032794869     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.1080/00016489950181008     Document Type: Article

References (25)

1. 1. Broekart D. The problem of middle ear cholesteatoma: etiology, genesis and pathobiology. A review. Acta Oto-Rhino-Laryngol Belg 1991; 45: 355-67.
2. 2. Kahonen K, Palva T, Bergoth V, Konttinen YV, Reitamo S. Immunohistochemical identification of inflammatory cells in secretory and chronic otitis media and cholesteatoma using monoclonal antibodies. Acta Otolaryngol (Stockh) 1984; 97: 431-6.
3. 3. Palva T, Taskinen E. Inflammatory cells in chronic middle ear disease. Acta Otolaryngol (Stockh) 1990; 109: 124-9.
4. 4. Shilling V, Bujia J, Negri B, Shulz P, Kastenbauer E. Immunologically activated cells in aural cholesteatoma. Am J Otolaryngol 1992; 12: 249-53.
5. 5. Negri B, Shilling V, Bujia J, Shulz P, Kastenbauer E. Immunotype findings in macrophages in aural cholesteatomas. Eur Arch Otorhinolaryngol 1992; 249: 87-90.
6. 6. Huang T, Shi-Du Y, Cheng-Chun H. Colony-stimulating factor in middle ear cholesteatoma. Am J Otolaryngol 1989; 10: 393-8.
7. 7. Ahn JM, Huang CC, Abramson M. Localization of interleukin-1 in human cholesteatoma. Am J Otolaryngol 1990; 11: 71-7.
8. 8. Kakiuchi H, Kinoshita K, Katoh Y, Tabata T. Interleukin-1 of cholesteatomatous keratinocytes. Ann Otol Rhinol Laryngol 1992; Suppl 157: 32-8.
9. 9. Shilling V, Negri B, Bujia J, Shulz P, Kastenbauer E. Possible role of Interleukin-1 alpha and Interleukin-1 beta in the pathogenesis of cholesteatoma of the middle ear. Am J Otol 1991; 12: 249-53.
10. 10. Bujia J, Kim C, Ostos P, Kastenbauer E, Hultner L. Role of interleukin 6 in epithelial hyperproliferation and bone resorption in middle ear cholesteatomas. Eur-Arch-Otorhinolaryngol. 1996; 253: 152-7.
11. 11. Shulz P, Bujia J, Holly A, Shilling V, Kastenbauer E. Possible autocrine growth stimulation of cholesteatoma epithelium by transforming growth factor alpha. Am J Otolaryngol 1993; 14: 82-7.
12. 12. Bujia J, Holly A, Shilling V, Negri B, Schulz P. Aberrant expression of epidermal growth factor receptor in aural cholesteatoma. Laryngoscope 1993; 103: 326-9.
13. 13. Bujia J, Holly A, Kim C, Schilling V, Kastenbauer E. Neue Aspekte zur Pathogenese des Cholesteatoms: Die mögliche Rolle einer durch Immunzellen induzierten Keratinozyten-Hyperproliferation. Laryngo-Rhino-Otologie 1993; 72: 279-83.
14. 14. Schlaak JF, Buslau M, Jochum W, et al. T-cells involved in psoriasis vulgaris belong to the Th1 subset. J Invest Dermatol 1994; 102: 145-9.
15. 15. Van Den Oord JJ, De Ley M, De Wolf-Peeters C. Distribution of gamma interferon receptors in normal and active psoriatic skin. In: Schlossman SF, Boumsell L, Gilks W, et al., editors. Leucocyte typing V. White cell differentiation antigens. Proceedings of the Fifth International Workshop and Conference (Boston, USA, 3-7 November 1993). Oxford: University Press, 1995: 1994-5.
16. 16. Fransson J, Hammar H. Epidermal growth in skin equivalent. Arch Dermatol Res 1992; 284: 343-8.
17. 17. Paukkonen K, Naukkarinen A, Horsmanheimo M. The development of manifest psoriatic lesions is linked with the appearance of ICAM-1 positively on keratinocytes. Arch Dermatol Res 1995; 287: 165-70.
18. 18. Wakita H, Takigawa M. E-selectin and vascular cell adhesion molecule-1 are critical for initial trafficking of helper-inducer/memory T-cells in psoriatic plaques. Arch Dermatol 1994; 130: 457-63.
19. 19. Berti E, Marzano A, Gitto R, Colonna C, Caputo R. Evaluation of the activation antigen panel on activated lymphoid cells. In: Schlossman SF, Boumsell L, Gilks W, et al., editors. Leucocyte typing V. White cell differentiation antigens. Proceeding of the Fifth International Workshop and Conference (Boston, USA, 3-7 November 1993). Oxford: University Press, 1995: 1183-4.
20. 20. Van Blitterwijk CA, Grote JJ. Cytokeratin expression in cholesteatoma matrix, meatal epidermis and middle ear epithelium. Acta Otolaryngol (Stockh) 1988; 105: 529-32.
21. 21. Bujia J, Shilling V, Holly A, Stammberger M, Kastenbauer E. Hyperproliferation-associated keratin expression in human middle ear cholesteatoma. Acta Otolaryngol (Stockh) 1993; 113: 364-8.
22. 22. Mayot D, Béné MC, Perrin C, Faure G. Restricted expression of Ki-67 in cholesteatoma epithelium. Arch Otolaryngol Head Neck Surg 1993; 119: 656-8.
23. 23. Dallari S, Cavani A, Bergamini G, Girolomoni G. Integrin expression in middle ear cholesteatoma. Acta Otolaryngol (Stockh) 1994; 114: 188-92.
24. 24. Ergun S, Zheng X, Carlsoo B. Antigen expression of epithelial markers, collagen IV and Ki67 in middle ear cholesteatoma. An immunohistochemical study. Acta Otolaryngol (Stockh) 1994; 114: 295-302.
25. 25. De Boer OJ, Verhagen CE, Visser A, Bos JD, Das PK. Cellular interactions and adhesion molecules in psoriatic skin. Acta Derm Venereol (Stockh) 1994; Suppl 186: 15-8.